Pure Global

Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti^® in Knee Cartilage Defects - Trial NCT06249828

Access comprehensive clinical trial information for NCT06249828 through Pure Global AI's free database. This phase not specified trial is sponsored by L&C Bio and is currently Recruiting. The study focuses on Osteoarthritis, Knee. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06249828
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06249828
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti^® in Knee Cartilage Defects
A Clinical Trial to Evaluate the Efficacy and Safety of Cartilage Regeneration in the Use of MegaCarti^® in Patients With Knee Joint Cartilage Injury: Multicenter, Independent Evaluator-subject Blinded, Microfracture-comparative, Randomized Clinical Study

Study Focus

Osteoarthritis, Knee

MegaCarti^®

Interventional

device

Sponsor & Location

L&C Bio

Gyeonggi-do,Gyeonggi-do,Seoul,Seoul, South Korea

Timeline & Enrollment

N/A

Jan 22, 2024

Apr 30, 2025

60 participants

Primary Outcome

MOCART score

Summary

Subjects aged 50 to 65 years with knee cartilage defects will undergo microfracture treatment
 for cartilage regeneration and MegaCarti^® will be applied.

ICD-10 Classifications

Chronic instability of knee
Injuries to the knee and lower leg
Gonarthrosis [arthrosis of knee]
Dislocation, sprain and strain of joints and ligaments of knee
Sprain and strain of other and unspecified parts of knee

Data Source

ClinicalTrials.gov

NCT06249828

Device Trial